Analyzing Bio-Key International Inc (BKYI)’s Gross, Operating, Pretax, and Net Margins

Bio-Key International Inc [BKYI] stock is trading at $1.50, up 4.17%. An important factor to consider is whether the stock is rising or falling in short-term value. The BKYI shares have gain 7.91% over the last week, with a monthly amount glided 36.36%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Bio-Key International Inc [NASDAQ: BKYI] stock has seen the most recent analyst activity on March 26, 2021, when Maxim Group upgraded its rating to a Buy but kept the price target unchanged to $6 for it.

Bio-Key International Inc [BKYI] stock has fluctuated between $0.52 and $3.22 over the past year. Bio-Key International Inc [NASDAQ: BKYI] shares were valued at $1.50 at the most recent close of the market.

Analyzing the BKYI fundamentals

Bio-Key International Inc [NASDAQ:BKYI] reported sales of 6.39M for the trailing twelve months, which represents a growth of 18.03%. Gross Profit Margin for this corporation currently stands at 0.15% with Operating Profit Margin at -1.45%, Pretax Profit Margin comes in at -1.47%, and Net Profit Margin reading is -1.42%. To continue investigating profitability, this company’s Return on Assets is posted at -1.42, Equity is -53.78 and Total Capital is -17.5. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 17.97.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3400 points at the first support level, and at 1.1800 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.8000, and for the 2nd resistance point, it is at 2.1000.

Ratios To Look Out For

For context, Bio-Key International Inc’s Current Ratio is 0.78. On the other hand, the Quick Ratio is 0.71, and the Cash Ratio is 0.31. Considering the valuation of this stock, the price to sales ratio is 0.73, the price to book ratio is 35.05.

Related Posts